MedTrace Logo

Relative Bioavailability Study

NCT02159313 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2016-02-18

No results posted yet for this study

Summary

To investigate relative bioavailability of crushed tablets suspended in apple sauce or water

Conditions

  • Healthy Volunteers

Interventions

DRUG

Riociguat(Adempas,BAY63-2521)

Single dose of a whole 2.5 mg riociguat tablet

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2014-09-30
Completion
2015-01-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02159313 on ClinicalTrials.gov